Beneficial effects of statin treatment on coronary microvascular dysfunction and left ventricular remodeling in patients with acute myocardial infarction

International Journal of Cardiology

Volumn 155, Issue 3, 2012, Pages 442-447

  Ishida, Kentaro ^a   Geshi, Toru ^a   Nakano, Akira ^a   Uzui, Hiroyasu ^a   Mitsuke, Yasuhiko ^a   Okazawa, Hidehiko ^a   Ueda, Takanori ^a   Lee, Jong Dae ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Acute myocardial infarction; Asymmetric dimethylarginine; Cardiac remodeling; Myocardial flow reserve; Statins

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMMONIA N 13; ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; PITAVASTATIN; PRAVASTATIN;

ACUTE HEART INFARCTION; ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY MICROVASCULAR DYSFUNCTION; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; FEMALE; FRACTIONAL FLOW RESERVE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; MALE; MICROANGIOPATHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; CORONARY CIRCULATION; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSITRON-EMISSION TOMOGRAPHY; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84857791667     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.11.015     Document Type: Article

References (36)

1. G. Mengozzi, R. Rossini, and C. Palagi Usefulness of intravenous myocardial contrast echocardiography in the early left ventricular remodeling in acute myocardial infarction Am J Cardiol 90 2002 713 719 (Pubitemid 35282468)
2. T. Geshi, A. Nakano, and H. Uzui Relationship between impaired microvascular function in the non-infarct-related area and left ventricular remodeling in patients with myocardial infarction Int J Cardiol 126 2008 366 373 (Pubitemid 351636357)
3. H. Miyazaki, H. Matsuoka, and J.P. Cooke Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis Circulation 99 1999 1141 1146 (Pubitemid 29120084)
4. R.H. Böger, S.M. Bode-Böger, and W. Thiele Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction, its role in hypercholesterolemia Circulaiton 98 1998 1842 1847 (Pubitemid 28509278)
5. F. Abbasi, T. Asagmi, and J.P. Cooke Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus Am J Cardiol 88 2001 1201 1203 (Pubitemid 33043860)
6. A. Surdacki, M. Nowicki, and J. Sandmann Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension J Cardiovasc Pharmacol 33 1999 652 658 (Pubitemid 29164831)
7. S.W. Bae, M.C. Stühlinger, and H.S. Yoo Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment Am J Cardiol 95 2005 729 733 (Pubitemid 40332650)
8. H. Päivä, J. Laakso, H. Laine, R. Laaksonen, J. Knuuti, and O.T. Raitakari Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia J Am Coll Cardiol 40 2002 1241 1247
9. A. Rezaie-Majd, T. Maca, and R.A. Bucek Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hyperchokesterolemic patients Arterioscler Thromb Vasc Biol 22 2002 1194 1199 (Pubitemid 34764873)
10. E. Karatzis, J. Lekakis, and C. Papamichael Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina Int J Cardiol 101 2005 65 70 (Pubitemid 40626725)
11. A. Undas, K.E. Brummel, J. Musial, K.G. Mann, and A. Szczeklik Simvastatin depresses blood clotting by inhibiting activation of prpthrombin, factor V, and factor XIII and by enhancing factor Va inactivation Circulation 103 2001 2248 2253 (Pubitemid 32433713)
12. U. Laufs, V. La Fata, J. Plutzly, and J.K. Liao Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors Circulation 97 1998 1129 1135 (Pubitemid 28152885)
13. Y. Kureishi, Z. Luo, and I. Shiojima The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals Nat Med 6 2000 1004 1010
14. Prevention of cardiovascular events and death with pravastatin in patients with coronary artery disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) study Group N Engl J Med 339 1998 1349 1357
15. H. Nakamura, K. Arakawa, and H. Itakura Primary prevention of cardiovascular disease in Japan (MEGA study): a prospective randomized controlled trial Lancet 368 2006 1155 1163 (Pubitemid 44444932)
16. Y. Teshima, K. Yufu, and H. Akioka Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction J Cardiol 53 2009 58 64
17. Y. Ohara, Y. Hiasa, and S. Hosokawa Impact of hydroxymethylglutaryl coenzyme A reducatase inhibition on left ventricular remodeling in patients with acute myocardial infarction after primary coronary angiography Int Heart J 46 2005 987 995
18. 3 and gated PET J Nucl Med 43 2002 999 1005 (Pubitemid 34847921)
19. 13N-ammonia and PET: comparison of tracer models J Nucl Med 40 1999 1045 1055 (Pubitemid 29269227)
20. 13N-ammonia PET and 99mTc sestamibi SPECT J Nucl Cardiol 5 1998 4 13 (Pubitemid 28084960)
21. K.L. Gould, J.P. Martucci, and D.I. Goldberg Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium Circulation 89 1994 1530 1538
22. M. Guethlin, A.M. Kasel, K. Coppenrath, S. Ziegler, W. Delius, and M. Schwaiger Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin Circulation 99 1999 475 481 (Pubitemid 29061861)
23. S.J. Hong, S.C. Choi, and J.S. Kim Low-dose versus moderate-dose atorvastatin after acute myocardial infarction: 8-month effects on coronary flow reserve and angiogenic cell mobilization Heart 96 2010 756 764
24. K.H. Yun, S.K. Oh, S.J. Rhee, N.J. Yoo, N.H. Kim, and J.W. Jeong 12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome Int J Cardiol 146 2011 68 72
25. T. Aoyagi, F. Nakamura, T. Tomaru, and T. Toyo-Oka Beneficial effects of pitavastatin, a 3-hydrpxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac function in ischemic and nonischemic heart failure Int Heart J 49 2008 49 58 (Pubitemid 351663723)
26. R.M. Bell, and D.M. Yellon Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway J Am Coll Cardiol 41 2003 508 515 (Pubitemid 36164511)
27. A. Ito, P.S. Tsao, S. Adimoolam, M. Kimoto, T. Ogawa, and J.P. Cooke Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase Circulation 99 1999 3092 3095 (Pubitemid 29289071)
28. R.H. Böger, K. Sydow, and J. Borlak LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases Circ Res 87 2000 99 105 (Pubitemid 30616904)
29. T.M. Lu, Y.A. Ding, H.B. Leu, W.H. Yin, W.H. Sheu, and K.M. Chu Effects of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia Am J Cardiol 94 2004 157 161 (Pubitemid 38902861)
30. Y. Nishiyama, M. Ueda, and T. Otsuka Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients J Atheroscler Thromb 18 2 2011 131 137
31. J.M. Young, C.H. Strey, and P.M. George Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ishchemic heart failure Eur J Heart Failure 10 2008 463 466
32. A. Yamamuro, T. Akasaka, and K. Tamita Coronary flow velocity pattern immediately after percutaneous coronary intervention as a predictor of complication and in-hospital survival after acute myocardial infarction Circulation 106 2002 3051 3056 (Pubitemid 35440287)
33. T. Sakamoto, S. Kojima, and H. Ogawa Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese Am J Cardiol 97 2006 1165 1171
34. G. Patti, C.P. Cannon, and S.A. Murphy Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies Circulation 123 2011 1622 1632
35. I. Yokoyama, Y. Inoue, T. Moritan, K. Ohtomo, and R. Nagai Impaired myocardial vasodilatation during hyperaemic stress is improved by simvastatin but not by pravastatin in patients with hypercholesterolaemia Eur Heart J 25 2004 671 679 (Pubitemid 38579496)
36. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2